Nisa Investment Advisors’s GSK GSK Stock Holding History

Nisa Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.99K	Buy	144 +67	+87%	+$3.63K	﹤0.01%	2315
2025 Q4	$3.79K	Buy	+77	New	+$3.59K	﹤0.01%	2506
2020 Q3	–	Sell	-880	Closed	-$45K	–	2255
2020 Q2	$45K	Hold	880	–	–	﹤0.01%	1604
2020 Q1	$42K	Hold	880	–	–	﹤0.01%	1562
2019 Q4	$52K	Hold	880	–	–	﹤0.01%	1521
2019 Q3	$47K	Hold	880	–	–	﹤0.01%	1538
2019 Q2	$44K	Hold	880	–	–	﹤0.01%	1520
2019 Q1	$46K	Hold	880	–	–	﹤0.01%	1534
2018 Q4	$42K	Hold	880	–	–	﹤0.01%	1466
2018 Q3	$44K	Buy	+880	New	+$44.7K	﹤0.01%	1484

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nisa Investment Advisors's GSK Position: Q1 2026 in Review

Nisa Investment Advisors increased its GSK (GSK) stake by 87% in Q1 2026, buying an estimated $3.63K and bringing the position to 144 shares worth $7.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2315.

Nisa Investment Advisors first reported a position in GSK in Q3 2018 and has held it in 10 quarters since. The position peaked at $52K in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Nisa Investment Advisors held 144 shares of GSK worth $7.99K as of Q1 2026.
Nisa Investment Advisors bought 67 GSK shares in Q1 2026, an estimated $3.63K.
GSK made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2315 holding.
Nisa Investment Advisors first reported a position in GSK in Q3 2018 and has held it in 10 quarters since.
Nisa Investment Advisors's GSK position peaked at $52K in Q4 2019.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.